Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Antimycobacterial activity of rhodamine 3,4-HPO iron chelators against Mycobacterium avium: analysis of the contribution of functional groups and of chelator's combination with ethambutol
Publication

Publications

Antimycobacterial activity of rhodamine 3,4-HPO iron chelators against Mycobacterium avium: analysis of the contribution of functional groups and of chelator's combination with ethambutol

Title
Antimycobacterial activity of rhodamine 3,4-HPO iron chelators against Mycobacterium avium: analysis of the contribution of functional groups and of chelator's combination with ethambutol
Type
Article in International Scientific Journal
Year
2015
Authors
Moniz, T
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Silva, D
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Silva, T
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Gomes, MS
(Author)
ICBAS
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Title: MedChemCommImported from Authenticus Search for Journal Publications
Vol. 6
Pages: 2194-2203
ISSN: 2040-2503
Other information
Authenticus ID: P-00J-YMB
Abstract (EN): Rhodamine-labelled 3-hydroxy-4-pyridinone (3,4-HPO) chelators exhibit antimycobacterial activity, related but not limited to their iron binding capacity. We previously found that bacterial growth inhibition observed for chelators with ethyl substituents on the amino groups of the xanthene ring of rhodamine and a thiourea linkage between rhodamine and the chelating unit (MRH7 and MRB7) was different from that of compounds with methyl substituents and an amide linkage (MRH8 and MRB8). In this work we evaluated the antimycobacterial activity of two new chelators (MRH10 and MRB9) expressly designed to allow: (a) the direct comparison of the influence of the functional groups per se and (b) identification of the finest combination to achieve a higher biological activity. The activity of the chelators was assessed, as previously, by measuring their effect against M. avium. In this study we also report the antimycobacterial effect of MRH7, which proved to be the best performer of all four chelators, in combination with ethambutol, which is one of the antibiotics currently in use to treat mycobacterial infections. The results are indicative that a combination of 3,4-HPO iron chelators with an antibiotic is a promising strategy to fight M. avium infections. The current results are relevant for the choice of the best chelator in our set of compounds and also for the design of novel molecular architectures to target cellular membranes.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 10
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

3-Substituted coumarins as dual inhibitors of AChE and MAO for the treatment of Alzheimer's disease (2012)
Article in International Scientific Journal
Viña, D; Matos, MJ; Yáñez, M; Santana, L; Uriarte, E
Synthesis of coumarin-chalcone hybrids and evaluation of their antioxidant and trypanocidal properties (2013)
Article in International Scientific Journal
Vazquez Rodriguez, S; Figueroa Guíñez, R; Matos, MJ; Santana, L; Uriarte, E; Lapier, M; Maya, JD; Olea Azar, C
Progress in the development of small molecules as new human A(3) adenosine receptor ligands based on the 3-thiophenylcoumarin core (2016)
Article in International Scientific Journal
Klotz, KN; Fernanda Borges; Matos, MJ; Vilar, S; Kachler, S; Vazquez Rodriguez, S; Varela, C; Delogu, G; Hripcsak, G; Santana, L; Uriarte, E
PRIMACINS, N-cinnamoyl-primaquine conjugates, with improved liver-stage antimalarial activity (2012)
Article in International Scientific Journal
Bianca Perez; Catia Teixeira; Ines S Albuquerque; Jiri Gut; Philip J Rosenthal; Miguel Prudencio; Paula Gomes
PRIMACENES: novel non-cytotoxic primaquine-ferrocene conjugates with anti-Pneumocystis carinii activity (2010)
Article in International Scientific Journal
Joana Matos; Nuno Vale; Margaret S Collins; Jiri Gut; Philip J Rosenthal; Melanie T Cushion; Rui Moreira; Paula Gomes

See all (9)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-09 at 09:09:01 | Privacy Policy | Personal Data Protection Policy | Whistleblowing